Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 217583
Company: FRESENIUS KABI USA
Company: FRESENIUS KABI USA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| MANGANESE CHLORIDE | MANGANESE CHLORIDE | EQ 0.1MG MANGANESE/ML | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/07/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
MANGANESE CHLORIDE
INJECTABLE;INJECTION; EQ 0.1MG MANGANESE/ML
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| MANGANESE CHLORIDE | MANGANESE CHLORIDE | EQ 0.1MG MANGANESE/ML | INJECTABLE;INJECTION | Prescription | No | AP | 217583 | FRESENIUS KABI USA |
| MANGANESE CHLORIDE IN PLASTIC CONTAINER | MANGANESE CHLORIDE | EQ 0.1MG MANGANESE/ML | INJECTABLE;INJECTION | Prescription | Yes | AP | 018962 | HOSPIRA |